Home
About
FAQ
History (5)
Association of left ventricular hypertrophy with cognitive decline and dementia risk over 20 years: The Atherosclerosis Risk In Communities-Neurocognitive Study (ARIC-NCS).
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial.
Pesticides present in migrant farmworker housing in North Carolina.
Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists.
The androgen receptor CAG repeat and prostate cancer risk.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The androgen receptor CAG repeat and prostate cancer risk.
Clark PE, Irvine RA, Coetzee GA. The androgen receptor CAG repeat and prostate cancer risk. Methods Mol Med. 2003; 81:255-66.
View in:
PubMed
subject areas
Case-Control Studies
Humans
Male
Polymerase Chain Reaction
Polymorphism, Genetic
Prostatic Neoplasms
Receptors, Androgen
Risk Factors
Trinucleotide Repeats
Tumor Cells, Cultured
authors with profiles
Peter E. Clark MD